This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa
The drug STOCRIN contains one active pharmaceutical ingredient (API):
1
Efavirenz
UNII JE6H2O27P8 - EFAVIRENZ
|
Efavirenz is a NNRTI of HIV-1. Efavirenz is a non-competitive inhibitor of HIV-1 reverse transcriptase (RT) and does not significantly inhibit HIV-2 RT or cellular DNA polymerases (α, β, γ or δ). |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
STOCRIN Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J05AG03 | Efavirenz | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10336B, 10366N |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 11593552 |
Country: EE | Ravimiamet | Identifier(s): 1044010, 1044021, 1044032, 1107368, 1127898, 1215267, 1303355, 1303366 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 99111001IP |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4709 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6250015F1022, 6250015F2029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1006447, 1006448, 1006449, 1011562, 1030885, 1030886, 1030887, 1030890, 1055420 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 427M2001 |
Country: NL | Z-Index G-Standaard | Identifier(s): 14715864 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 61166, 66834, 84794, 84956 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 10297, 12289, 12290 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100091726, 100093116, 100093122, 100093145, 100109403, 100167607, 100167688 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W64652001 |
Country: SG | Health Sciences Authority | Identifier(s): 12064P, 13508P, 13509P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 3443022H, 7013111H, 7013112H |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699636010273 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 37/20.2.8/0628, A40/20.2.8/0736, A40/20.2.8/0737 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.